🇺🇸 FDA
Patent

US 8263777

Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase

granted A61PA61P11/00A61P29/00

Quick answer

US patent 8263777 (Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P11/00, A61P29/00, A61P35/00, A61P35/04